Clinical Trials Browser

dubermatinib × Other hematologic neoplasm × Clear all

NCT03572634 2023-11-09

Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL

Phase 1/2 Terminated

3 enrolled 7 charts

LymphoidOther hematologic neoplasm

Neoplasms, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04518345 2023-02-06

TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia

Phase EARLY_PHASE1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute